论文部分内容阅读
本文介绍了肿瘤病人,尤以急性白血病病人,在化疗中发生中性拉细胞减少并继发感染时的治疗及其他处理。文中所介绍的处理原则值得临床上重视,因为对重度中性粒细胞减少并继发感染的病人,延迟或处理不当很可能会造成难以挽回的结局。文中所介绍的一些新抗菌素,有的国内已生产,有的可能不久便会试产,可供今后参考。
This article describes the treatment of cancer patients, especially acute leukemia, in the treatment of neutropenia and subsequent infection and other treatments. The treatment principles presented here deserve clinical importance, as delaying or mismanaging patients with severe neutropenia and subsequent infection is likely to result in irreparable consequences. Some of the new antibiotics introduced in this article have been produced domestically and some may be trial-produced shortly for future reference.